METHODS: Patients were identified via a medical record query of commonly used CPT
codes for pelvic pain. Patients were contacted via phone then emailed an anonymous online …

Background: Chronic pelvic pain (CPP) affects up to 15% of women in the United States.
The endocannabinoid system is a potential pharmacological target for pelvic pain as …

Chronic pelvic pain affects women across all demographics. Its management is complex and
requires a multimodal approach. Cannabis has been legal for medical purposes for many …

OBJECTIVE: To evaluate the prevalence and characteristics of recreational cannabis use in
women with pelvic pain, and to examine the influence of cannabis legalization on these …

OBJECTIVE: The endocannabinoid system is involved in pain perception and inflammation.
Cannabis contains delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), which are …

Objective To provide health care providers with the best evidence on cannabis use with
respect to women's health. Areas of focus include general patterns of cannabis use as well …

Research within a gynecologic oncology population has lagged behind the uptake in use of
medical cannabis for symptom control. This study seeks to evaluate patient experience with …

Background The use of cannabis for symptoms of endometriosis was investigated utilising
retrospective archival data from Strainprint Technologies Ltd., a Canadian data technology …

ABSTRACT BACKGROUND AND OBJECTIVES: Endometriosis is a common gynecological
condition, which affects 10% to 15% of women in the reproductive period and up to half of …

Cannabis sativa (L), a plant with an extensive history of medicinal usage across numerous
cultures, has received increased attention over recent years for its therapeutic potential for …